GR3035581T3 - Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides - Google Patents
Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptidesInfo
- Publication number
- GR3035581T3 GR3035581T3 GR20010400194T GR20010400194T GR3035581T3 GR 3035581 T3 GR3035581 T3 GR 3035581T3 GR 20010400194 T GR20010400194 T GR 20010400194T GR 20010400194 T GR20010400194 T GR 20010400194T GR 3035581 T3 GR3035581 T3 GR 3035581T3
- Authority
- GR
- Greece
- Prior art keywords
- pct
- date
- pseudopeptides
- sec
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13882093A | 1993-10-15 | 1993-10-15 | |
| PCT/US1994/012135 WO1995010295A1 (en) | 1993-10-15 | 1994-10-17 | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3035581T3 true GR3035581T3 (en) | 2001-06-29 |
Family
ID=22483811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20010400194T GR3035581T3 (en) | 1993-10-15 | 2001-03-15 | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5866685A (el) |
| EP (1) | EP0812205B1 (el) |
| JP (1) | JP3032297B2 (el) |
| KR (1) | KR100304332B1 (el) |
| CN (1) | CN1135717A (el) |
| AT (1) | ATE199727T1 (el) |
| AU (1) | AU703854B2 (el) |
| BG (1) | BG63166B1 (el) |
| BR (1) | BR9407839A (el) |
| CA (1) | CA2174097C (el) |
| CZ (1) | CZ291378B6 (el) |
| DE (1) | DE69426897T2 (el) |
| DK (1) | DK0812205T3 (el) |
| ES (1) | ES2155122T3 (el) |
| FI (1) | FI961634A (el) |
| GR (1) | GR3035581T3 (el) |
| HK (1) | HK1006225A1 (el) |
| HU (1) | HU222248B1 (el) |
| NO (1) | NO961460L (el) |
| NZ (1) | NZ275948A (el) |
| PL (1) | PL181749B1 (el) |
| PT (1) | PT812205E (el) |
| RO (1) | RO115520B1 (el) |
| RU (1) | RU2134695C1 (el) |
| SG (1) | SG64919A1 (el) |
| SK (1) | SK47796A3 (el) |
| UA (1) | UA44258C2 (el) |
| WO (1) | WO1995010295A1 (el) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274705B1 (en) * | 1996-05-02 | 2001-08-14 | Aventis Pharmaceuticals Products Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| HU222248B1 (hu) * | 1993-10-15 | 2003-05-28 | Aventis Pharmaceuticals Inc. | Trombózis elleni hatású (aza-cikloalkil)-alkanoil-peptidek, -pszeudopeptidek és ezeket a vegyületeket tartalmazó gyógyászati készítmények |
| CN1491942A (zh) * | 1996-08-21 | 2004-04-28 | ���µ�˹ҩ����Ʒ��˾ | N-[n-n-(4-（哌啶-4-基)丁酰基)-n-乙基甘氨酰基]化合物的不吸湿的稳定结晶形式 |
| IL129877A (en) * | 1996-11-27 | 2004-08-31 | Aventis Pharm Prod Inc | A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent |
| WO1999019294A1 (en) * | 1997-05-14 | 1999-04-22 | Aventis Pharmaceuticals Products Inc. Legal/Patents | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| JP2001519411A (ja) * | 1997-10-10 | 2001-10-23 | アヴェンティス ファーマシューティカルズ プロダクツ インコーポレイテッド | アザシクロアルキルアルカノイルプソイドテトラぺプチドの調製方法 |
| EP1155033A1 (en) * | 1998-12-30 | 2001-11-21 | Aventis Pharmaceuticals Products Inc. | Process for preparing a stable non-hygroscopic crystalline n-[n-[n-(piperdin-4-yl)butanoyl)-n-ethylglycyl]-(l)-aspartyl]-ss-cyclohexylalanine amide |
| CN101735307B (zh) * | 2008-11-18 | 2012-05-30 | 北京航空航天大学 | 一种血小板膜糖蛋白寡肽或其修饰物/衍生物以及它们的应用 |
| US9168233B2 (en) * | 2012-06-11 | 2015-10-27 | The Cleveland Clinic Foundation | Treatment and prevention of cardiovascular disease and thrombosis |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
| FR2608160B1 (fr) * | 1986-12-15 | 1989-03-31 | Inst Nat Sante Rech Med | Nouveaux derives peptidiques et leur application notamment en therapeutique |
| US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
| US4879313A (en) * | 1988-07-20 | 1989-11-07 | Mosanto Company | Novel platelet-aggregation inhibitors |
| US5037808A (en) * | 1988-07-20 | 1991-08-06 | Monsanto Co. | Indolyl platelet-aggregation inhibitors |
| US4992463A (en) * | 1988-07-20 | 1991-02-12 | Monsanto Company | Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation |
| US5023233A (en) * | 1989-07-28 | 1991-06-11 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| AU646411B2 (en) * | 1989-09-29 | 1994-02-24 | Rhone-Poulenc Rorer International (Holdings) Inc. | Anti-thrombotic peptides and pseudopeptides |
| US5051405A (en) * | 1989-10-10 | 1991-09-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptides and pseudopeptides |
| US5064814A (en) * | 1990-04-05 | 1991-11-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
| IL99539A0 (en) * | 1990-09-27 | 1992-08-18 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical compositions containing them |
| WO1992018117A1 (en) * | 1991-04-11 | 1992-10-29 | Rhone-Poulenc Rorer International (Holdings), Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
| HU222248B1 (hu) * | 1993-10-15 | 2003-05-28 | Aventis Pharmaceuticals Inc. | Trombózis elleni hatású (aza-cikloalkil)-alkanoil-peptidek, -pszeudopeptidek és ezeket a vegyületeket tartalmazó gyógyászati készítmények |
-
1994
- 1994-10-17 HU HU9600983A patent/HU222248B1/hu not_active IP Right Cessation
- 1994-10-17 JP JP7512250A patent/JP3032297B2/ja not_active Expired - Fee Related
- 1994-10-17 AT AT95900403T patent/ATE199727T1/de not_active IP Right Cessation
- 1994-10-17 DK DK95900403T patent/DK0812205T3/da active
- 1994-10-17 UA UA96051845A patent/UA44258C2/uk unknown
- 1994-10-17 CA CA002174097A patent/CA2174097C/en not_active Expired - Fee Related
- 1994-10-17 SK SK477-96A patent/SK47796A3/sk unknown
- 1994-10-17 WO PCT/US1994/012135 patent/WO1995010295A1/en active IP Right Grant
- 1994-10-17 DE DE69426897T patent/DE69426897T2/de not_active Expired - Lifetime
- 1994-10-17 US US08/628,648 patent/US5866685A/en not_active Expired - Lifetime
- 1994-10-17 PL PL94313975A patent/PL181749B1/pl unknown
- 1994-10-17 CN CN94194242A patent/CN1135717A/zh active Pending
- 1994-10-17 RO RO96-00812A patent/RO115520B1/ro unknown
- 1994-10-17 KR KR1019960701992A patent/KR100304332B1/ko not_active IP Right Cessation
- 1994-10-17 EP EP95900403A patent/EP0812205B1/en not_active Expired - Lifetime
- 1994-10-17 ES ES95900403T patent/ES2155122T3/es not_active Expired - Lifetime
- 1994-10-17 PT PT95900403T patent/PT812205E/pt unknown
- 1994-10-17 SG SG1996008589A patent/SG64919A1/en unknown
- 1994-10-17 BR BR9407839A patent/BR9407839A/pt not_active Application Discontinuation
- 1994-10-17 RU RU96109375/04A patent/RU2134695C1/ru not_active IP Right Cessation
- 1994-10-17 NZ NZ275948A patent/NZ275948A/en unknown
- 1994-10-17 AU AU81237/94A patent/AU703854B2/en not_active Ceased
- 1994-10-17 CZ CZ19961084A patent/CZ291378B6/cs not_active IP Right Cessation
-
1996
- 1996-04-12 NO NO961460A patent/NO961460L/no not_active Application Discontinuation
- 1996-04-12 FI FI961634A patent/FI961634A/fi unknown
- 1996-04-26 BG BG100544A patent/BG63166B1/bg unknown
-
1998
- 1998-06-16 HK HK98105458A patent/HK1006225A1/xx not_active IP Right Cessation
-
2001
- 2001-03-15 GR GR20010400194T patent/GR3035581T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU93054168A (ru) | Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе | |
| WO2001078709A3 (en) | Treatment of neurodegenerative disease | |
| IL113941A (en) | Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them | |
| BG103521A (en) | Substituted pyrimidinon and pyridon compounds and methods for their application | |
| FR2699077B1 (fr) | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. | |
| CA2288143A1 (en) | Activated protein c formulations | |
| IL112111A0 (en) | Peptide derivatives and pharmaceutical compositions containing them | |
| HU9600983D0 (en) | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | |
| DE69521536D1 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| EP1538163A3 (en) | Phosphorylated Amyloid-Beta 1-43 Protein and its use in the treatment of Alzheimer's disease | |
| HU9501542D0 (en) | Antithrombotic | |
| BG103512A (en) | Substituted pyramidine compounds and their application | |
| MXPA03011502A (es) | Aminoalcoholes sustituidos utiles en tratamiento de enfermedad de alzheimer. | |
| CA2179857A1 (en) | Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury | |
| BG102079A (en) | Alkylaminoderivatives of substituted quinoxalin-2,3-dions such as glutamatereceptor antagonists | |
| CA2065889A1 (en) | Increasing the choroidal blood flow | |
| GR3034142T3 (en) | Composition for the treatment or prevention of herpes | |
| CA2135752A1 (en) | Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease | |
| NO961357L (no) | Nye terapeutisk aktive peptidforbindelser i blodkoagulasjonskaskaden, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| ES2058025A1 (es) | Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica. | |
| CA2060333A1 (en) | Use of pyrimido-benzothiazine derivatives | |
| RU95104302A (ru) | Аппликационный материал лечебно-профилактического назначения | |
| IT1264562B1 (it) | Composizione farmaceutica per l'applicazione topica di 17,b estradiolo nel trattamento della cheratocongiuntivite sicca |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |